Bio-Path Holdings (BPTH) Reports Q3 Loss of $0.02/Share

Bio-Path Holdings (NASDAQ: BPTH) reported Q3 EPS of ($0.02), versus ($0.01) reported last year.

As of September 30, 2015, the Company had cash of $9.9 million, compared to $13.9 million at December 31, 2014. Net cash used in operating activities for the nine months ended September 30, 2015 was $4.0 million, compared to $2.7 million for the comparable period in 2014.

For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• SpaceX guide: Everything you need to know about the biggest IPO in history
• Guggenheim Reiterates Buy Rating on StubHub Holdings (STUB)